Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed or Refractory B-cell Non-hodgkin Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05674175
What this trial is testing

Co-administration of CART22-65s and huCART19 for B-ALL

Who this might be right for
B-cell Acute Lymphoblastic LeukemiaB Lineage Lymphoblastic Lymphoma
Stephan Grupp MD PhD 93
Testing effectiveness (Phase 2)Active Not RecruitingNCT00466531
What this trial is testing

Treatment of Relapsed or Chemotherapy Refractory Chronic Lymphocytic Leukemia or Indolent B Cell Lymphoma Using Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19

Who this might be right for
Leukemia
Memorial Sloan Kettering Cancer Center 50
Testing effectiveness (Phase 2)Study completedNCT01458366
What this trial is testing

Phase I/II Study of Bendamustine in Combination With Ofatumumab, Carboplatin and Etoposide

Who this might be right for
Non-Hodgkin's Lymphoma
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 38
Testing effectiveness (Phase 2)Study completedNCT06705530
What this trial is testing

Evaluate the Tolerability, Safety, and Efficacy of an Anti-CD19 CAR-T Product in Patients With B-cell Lymphoproliferative Disorders

Who this might be right for
Non-Hodgkin Lymphoma, B-cellAcute Lymphoblastic Leukemia ALL
National Research Center for Hematology, Russia 58
Early research (Phase 1)WithdrawnNCT03920631
What this trial is testing

Microtransplantation and Checkpoint Blockade Immunotherapy for Relapsed or Refractory B Cell Lymphomas

Who this might be right for
B Cell Lymphomas
Ahmed Galal, MD
Early research (Phase 1)Ended earlyNCT00033423
What this trial is testing

Radiolabeled Monoclonal Antibody in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
University of Alabama at Birmingham 18
Very early researchUnknownNCT03825731
What this trial is testing

GC022 CAR-T Cell Immunotherapy for Relapsed or Refractory B- ALL

Who this might be right for
B-cell Acute Lymphoblastic Leukemia
Hebei Yanda Ludaopei Hospital 20
Testing effectiveness (Phase 2)UnknownNCT03185494
What this trial is testing

Treatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by Tandem CAR T Cells Targeting CD19 and CD22

Who this might be right for
Hematopoietic/Lymphoid CancerAdult Acute Lymphoblastic Leukemia in RemissionB-cell Adult Acute Lymphoblastic Leukemia+20 more
Chinese PLA General Hospital 30
Early research (Phase 1)Ended earlyNCT03892525
What this trial is testing

Study of Intratumoral Selicrelumab With Atezolizumab in Patients With Refractory or Relapsed B Cell Lymphoma

Who this might be right for
Recurrent B-Cell Non-Hodgkin LymphomaRefractory B-Cell Non-Hodgkin Lymphoma
The Lymphoma Academic Research Organisation 4
Early research (Phase 1)Study completedNCT03688152
What this trial is testing

A Safety and Tolerability Study of INCB053914 in Combination With INCB050465 in Diffuse Large B-Cell Lymphoma

Who this might be right for
Relapsed Diffuse Large B-Cell LymphomaRefractory Diffuse Large B-Cell Lymphoma
Incyte Corporation 9
Testing effectiveness (Phase 2)Study completedNCT01431209
What this trial is testing

Ruxolitinib Phosphate to Treat Diffuse Large B-Cell or Peripheral T-Cell Non-Hodgkin Lymphoma After Stem Cell Transplant

Who this might be right for
Recurrent Diffuse Large B-Cell LymphomaRecurrent Mature T- and NK-Cell Non-Hodgkin LymphomaRefractory Diffuse Large B-Cell Lymphoma+1 more
University of Nebraska 71
Early research (Phase 1)Study completedNCT00621452
What this trial is testing

Genetically Engineered Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or Indolent B-Cell Non-Hodgkin Lymphoma

Who this might be right for
B-cell Chronic Lymphocytic LeukemiaExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell Lymphoma+8 more
Fred Hutchinson Cancer Center 12
Early research (Phase 1)Study completedNCT00709033
What this trial is testing

T-cells or EBV Specific CTLs, Advanced B-Cell NHL and CLL

Who this might be right for
Non-Hodgkin LymphomaChronic Lymphocytic Leukemia
Baylor College of Medicine 3
Early research (Phase 1)Ended earlyNCT00933985
What this trial is testing

Obatoclax Mesylate, Vincristine Sulfate, Doxorubicin Hydrochloride, and Dexrazoxane Hydrochloride in Treating Young Patients With Relapsed or Refractory Solid Tumors, Lymphoma, or Leukemia

Who this might be right for
Acute Leukemias of Ambiguous LineageAcute Undifferentiated LeukemiaAngioimmunoblastic T-cell Lymphoma+26 more
National Cancer Institute (NCI) 22
Early research (Phase 1)UnknownNCT04653493
What this trial is testing

CD19 Targeted CAR T Cell Therapy in Patients With Relapsed/ Refractory B Cell Acute Lymphoblastic Leukaemia (ALL)

Who this might be right for
Relapsed B Cell Acute Lymphoblastic Leukemia (ALL)Refractory B Cell Acute Lymphoblastic Leukemia (ALL)
Sabz Biomedicals 22
Early research (Phase 1)Study completedNCT01300026
What this trial is testing

AMG 319 Lymphoid Malignancy FIH

Who this might be right for
CancerChronic Lymphocytic LeukemiaDiffuse Large Cell Lymphoma+11 more
Amgen 28
Testing effectiveness (Phase 2)Study completedNCT00086944
What this trial is testing

Oblimersen, Rituximab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma

Who this might be right for
Recurrent Adult Diffuse Large Cell LymphomaRecurrent Grade 3 Follicular LymphomaRecurrent Mantle Cell Lymphoma
National Cancer Institute (NCI) 25
Post-approval studies (Phase 4)Study completedNCT01990534
What this trial is testing

Brentuximab Vedotin in Participants With Relapsed or Refractory Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
Millennium Pharmaceuticals, Inc. 60
Early research (Phase 1)Study completedNCT03798314
What this trial is testing

Nivolumab and Pomalidomide in Treating Patients With Relapsed or Refractory Central Nervous System Diffuse Large B Cell Lymphoma or Primary Vitreoretinal Diffuse Large B Cell Lymphoma

Who this might be right for
Recurrent Nervous System LymphomaRecurrent Primary Vitreoretinal DLBCLRefractory Nervous System Lymphoma+1 more
Mayo Clinic 3
Early research (Phase 1)Active Not RecruitingNCT05574114
What this trial is testing

Radiation Therapy Before CAR T Cell Therapy for People With B Cell Lymphoma

Who this might be right for
Non-Hodgkin LymphomaNon-Hodgkin's Lymphoma, RelapsedNon-Hodgkin's Lymphoma Refractory
Memorial Sloan Kettering Cancer Center 20
Next Page